American Journal of Ophthalmology
Volume 147, Issue 2 , Pages 198-205.e1, February 2009

Tear Cytokine Profiles in Dysfunctional Tear Syndrome

  • Helene Lam

      Affiliations

    • Department of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas
  • ,
  • Lauren Bleiden

      Affiliations

    • Department of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas
  • ,
  • Cintia S. de Paiva

      Affiliations

    • Department of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas
  • ,
  • William Farley

      Affiliations

    • Department of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas
  • ,
  • Michael E. Stern

      Affiliations

    • Department of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas
  • ,
  • Stephen C. Pflugfelder

      Affiliations

    • Department of Ophthalmology, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas
    • Allergan Inc, Irvine, California
    • Corresponding Author InformationInquiries to Stephen C. Pflugfelder, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin NC205, Houston, Texas 77030

Accepted 21 August 2008. published online 07 November 2008.

Purpose

To compare tear cytokine and chemokine concentrations in asymptomatic control and Dysfunctional Tear syndrome (DTS) patients and determine the correlations between tear inflammatory mediators and clinical severity.

Design

Prospective observational cohort study.

Methods

Concentrations of epidermal growth factor (EGF), interleukin (IL)-1 alpha (1α), 1 beta (1β), 6, 10, 12, and 13, interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), and chemokines: IL-8 (CXC); macrophage inflammatory protein-1 alpha (MIP-1α) (CCL3); and regulated upon activation, normal T-cell expressed and secreted (RANTES CCL5) were measured by a multiplex immunobead assay in an asymptomatic control group and DTS patients with and without meibomian gland disease (MGD). Spearman correlations between tear cytokines and severity of irritation symptoms and ocular surface signs were calculated.

Results

Tear concentrations of IL-6, IL-8 and TNF-α were significantly higher in DTS with and without MGD and EGF was significantly reduced in the DTS without MGD group compared with the control group. MIP-1α was greater in entire DTS and DTS without MGD groups than the control group and RANTES was greater in DTS with MGD than the control and DTS without MGD groups. IL-12 was significantly higher in the DTS with MGD than the DTS without MGD subgroup. Significant correlations were observed between IL-6 and irritation symptoms and between a number of cytokines and chemokines and clinical parameters.

Conclusions

As predicted, patients with DTS have higher levels of inflammatory mediators in their tears that show correlation with clinical disease parameters. Furthermore, different tear cytokine/chemokine profiles were observed in DTS patients with and without MGD groups.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9394(08)00690-9

doi:10.1016/j.ajo.2008.08.032

American Journal of Ophthalmology
Volume 147, Issue 2 , Pages 198-205.e1, February 2009